Tafinlar 75 MG capsule 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FR0NV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,321
Award facts
- Contract value 100% obligated
- $10,321.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,321.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 23, 2026, for the supply of Tafinlar 75 mg capsules (120-count units), with performance completion scheduled for February 13, 2026. The contract will be performed at the awardee's facility in Conshohocken, Pennsylvania, and was awarded on a non-set-aside, competitive basis. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen functions as a major pharmaceutical distributor within the federal medical supply chain, delivering an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to military treatment facilities and veterans' healthcare programs. Tafinlar, a specialty oncology medication, exemplifies the company's role in providing critical pharmaceutical commodities to support the Defense Health Agency and other federal healthcare systems. The parent organization, Cencora, Inc., holds significant market position in federal pharmaceutical distribution, competing on a full and open basis without set-aside restrictions, and maintaining additional contracts with the Department of Veterans Affairs and the Federal Bureau of Investigation.
Quick answers
Who was awarded contract SPE2DR26FR0NV?
SPE2DR26FR0NV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FR0NV worth?
The government has obligated $10,321 on SPE2DR26FR0NV.
Is contract SPE2DR26FR0NV an order under another contract?
Yes. SPE2DR26FR0NV is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0NV competed?
The extent of competition for SPE2DR26FR0NV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award